Medical Specialties News Pharma & Biotechnology

North America Genome Editing Market Facts & Figures by Horizon Discovery Group plc, Sangamo Therapeutics, Inc., New England Biolabs

The North America genome editing market accounted to US$ 1,234.5 Mn in 2017 and is expected to grow at a CAGR of 17.2% during the forecast period 2018 – 2025, to account to US$ 4,148.1 Mn by 2025.

The Asia Pacific genome editing market is expected to grow at highest rate during the forecast period owing to increasing investments by the governments of the respective countries in the region. In addition, the rise in the development and research for the genome editing along with the clinical trials are expected to fuel the market growth in Asia Pacific region.

To Know How COVID-19 Pandemic Will Impact Global North America Genome Editing Market | Get a Sample Copy of Report, Click Here: https://www.theinsightpartners.com/sample/TIPRE00003907/

Market Insights

Rise in the Production of Genetically Modified Crops

The genome editing has proved itself to be the most promising way of feeding the fast growing population across the world. The changes in the climatic conditions due to the global warming and others conditions such as droughts floods are witnessed more across the world. Therefore the feeding the rising population is question among the people across the world. Due to the genome editing the concerns are being reduced to a great level, the two types of the genetically modified crops are widely grown. Firstly, these crops are altered in a ways that they are not affected by the herbicide glyphosate. Secondly, crops are produced to protect themselves from the insecticides.

In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

Transposagen Biopharmaceuticals, Inc.
Integrated DNA Technologies, Inc.
Thermo Fisher Scientific Inc.
GenScript
Lonza
Horizon Discovery Group plc
Sangamo Therapeutics, Inc.
New England Biolabs
Editas Medicine
Merck KGaA

The advantages of the genetically modified crops includes diseases resistance, improvement of the photosynthesis, improvement of the nutrition, and more. The genetic modification helps to enhance the productivity without hampering the health of the crops. In addition, for the genetically modified crops the limited resources are required and it require less or no pesticides for its growth. The time required for the growth of the genetically modified crops is less, therefore these are highly preferred crops in the western world. The demand for the genetically modified crops is rising in the eastern region due to the benefits offered by these crops.

Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in North America genome editing industry. Few of the recent product launch and product approval are listed below:

2018: Thermo Fisher Scientific announced the acquisition of IntegenX. IntegenX has been developing rapid DNA testing technology for human identification for use in forensics and law enforcement. The company in 2015, has launched RapidHIT System, which is the first-generation STR-based human identification system that is also compatible with Thermo Fisher’s STR kits.

2017: Integrated DNA Technologies announced the product launch of variants of the first Cas9 enzyme. These are used for extensive reduction off-target effects in CRISPR genome editing and does not compromise on-target activity. The Alt-R S.p. HiFi Cas9 Nuclease 3NLS enzyme is a recombinant S. pyogenes Cas9 mutant improvises the specificity and also maintenance a high editing efficiency similar to wild-type Cas9.

2016: GenScript announced the launch of its new service CRISPR based Yeast Genome Editing Service. The service utilizes the λ Red-CRISPR/Cas9 technology.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post the COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

The report is a combination of qualitative and quantitative analysis of the Glycomics industry. The global market majorly considers five major regions, namely, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America (SACM). The report also focuses on the exhaustive PEST analysis and extensive market dynamics during the forecast period.

Interested in Purchasing this Report? Click here @ https://www.theinsightpartners.com/buy/TIPRE00003907/

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.

Contact Us:

Call: +1-646-491-9876
Email: sales@theinsightpartners.com
LinkedIn- https://www.linkedin.com/company/business-market-insights/

Prashant Tambe
Prashant Tambe
An expert in SEO, Prashant carries an experience of over five years in the industry. He has the ability to analyze global industry trends that helps the leaders to make smarter decisions. An electrical, electronics and communication engineer, Prashant is able to predict future trends as they are changing fast with technological development.